NE

Natalya Evseyko

Active Director Director DIN 08004211
DIN 08004211 First appointment Dec 2017 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Dec 2017
Shareholding value Locked Premium profile

About Natalya Evseyko

Natalya Evseyko has 8 years in corporate governance. Holds Director role. Currently with 1 company, including Medient Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08004211
Primary Designation Director
First Appointment 26 Dec 2017
Oldest Company Age 11 yrs

Current companies

Company Designation Appointment Founded Status
Director 26 Dec 2017 2015 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Medient Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Natalya Evseyko

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Natalya Evseyko

Natalya Evseyko has 8 years in corporate governance. Holds Director role. Currently with 1 company, including Medient Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Natalya Evseyko is associated with 1 company as Director.

Natalya Evseyko has expertise in General Business.

Natalya Evseyko has 8 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available